Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer

Breast Cancer Research and Treatment

Volumn 95, Issue 1, 2006, Pages 1-6

  Ozmen, V ^a   Karanlik, H ^a   Cabioglu, N ^b   Igci, A ^a   Kecer, M ^a   Asoglu, O ^a   Tuzlali, S ^a   Mudun, A ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Haseki Training and Research Hospital   (Turkey)

Author keywords

Breast carcinoma; Micrometastasis; Non sentinel lymph node metastasis; Sentinel lymph node metastasis

Indexed keywords

ISOSULFAN BLUE; NANACIS; RADIOPHARMACEUTICAL AGENT; RHENIUM SULFATE TC 99M; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNAL MAMMARY LYMPH NODE; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TISSUE SECTION; TUMOR CELL; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY;

EID: 32444449212     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9007-9     Document Type: Article

References (51)

1. Fisher ER, Anderson S, Redmond C, Fisher B: Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06: 10-year pathologic and clinical prognostic discriminants. Cancer 71: 2507-2514, 1993
2. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP: Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45: 2917-2924, 1980
3. Galea MH, Blamey RW, Elston CW, Ellis IO: The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat. 22: 207-219, 1992
4. Kollias J, Murphy CA, Elston CW, Ellis IO, Robertson JF, Blamey RW: The prognosis of small primary breast cancers. Eur J Cancer 35: 908-912, 1999
5. Ozmen V, Muslumanoglu M, Cabioglu N, et al.: Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Breast Cancer Res Treat 76: 237-244, 2002
6. Noguchi M: Current controversies concerning sentinel lymph node biopsy for breast cancer. Breast Cancer Res Treat 84: 261-271, 2004
7. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15: 2345-2350, 1997
8. Schrenk P, Shamiyeh A, Wayand W: Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients. Eur J Surg Oncol 27: 378-382, 2001
9. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391-401, 1994
10. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 339: 941-946, 1998
11. Albertini JJ, Lyman GH, Cox C, et al.: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276: 1818-1822, 1996
12. Czerniecki BJ, Scheff AM, Callans LS, et al.: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel node biopsy in patients with breast cancer. Cancer 85: 1098-1103, 1999
13. Barnwell JM, Arredondo MA, Kollmorgen D, et al.: Sentinel node biopsy in breast cancer. Ann Surg Oncol 5: 126-130, 1998
14. Galimberti V, Zurrida S, Zucali P, et al.: Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? The Breast 7: 8-10, 1998
15. Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE: Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol 6: 756-761, 1999
16. Liang WC, Sickle-Santanello BJ, Nims TA: Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am J Surg 182: 365-368, 2001
17. van Iterson V, Leidenius M, Krogerus L, von Smitten K: Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes. Breast Cancer Res Treat 82: 39-45, 2003
18. Reitsamer R, Peintinger F, Prokop E, Rettenbacher L, Menzel C: 200 Sentinel lymph node biopsies without axillary lymph node dissection -no axillary recurrences after a 3-year follow-up. Br J Cancer 90: 1551-1554, 2004
19. Veronesi U, Paganelli G, Viale G, et al.: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349: 546-553, 2003
20. Ross MI: Sentinel node dissection in early-stage breast cancer: Ongoing prospective randomized trials in the USA. Ann Surg Oncol 8: 77-81, 2001
21. Reynolds C, Mick R, Donohue JH, et al.: Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17: 1720-1726, 1999
22. Singletary SE, Allred C, Ashley P, et al.: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20: 3628-3636, 2002
23. Eroglu A, Mudun A, Ozmen V, et al.: Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. Clin Nucl Med 29: 306-11, 2004
24. Fournier K, Schiller A, Perry RR, Laronga C: Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg 239: 859-865, 2004
25. Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R: Sentinel lymph node micrometastasis as a predictor of axillary tumor burden. Breast J 10: 101-105, 2004
26. Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A: Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol 28: 623-626, 2002
27. Bader AA, Tio J, Petru E, et al.: T1 breast cancer: identification of patients at low risk of axillary lymph node metastases. Breast Cancer Res Treat 76: 11-17, 2002
28. Nos C, Harding-MacKean C, Fréneaux P, et al.: Prediction of tumor involvement in remaining axillary lymph nodes when the sentinel node in a women with breast cancer contains metastases. Br J Surg 90: 1354-1360, 2003
29. Silverstein M, Skinner KA, Lomis TJ: Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 25: 767-72, 2001
30. Barth A, Craig P, Silverstein MJ: Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 79: 1918-22, 1997
31. Gajdos C, Tartter PI, Bleiweiss IJ: Lymphatic invasion, tumor size and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg 220: 692-696, 1999
32. Andea AA, Bouwman D, Wallis T, Visscher DW: Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 100: 20-27, 2004
33. Moore KH, Thaler HT, Tan LK, Borgen PI, Cody III HS: Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact?. Cancer 100: 929-934, 2004
34. Viale G, Zurrida S, Maiorano E, et al.: Predicting the status of axillary sentinel lymph nodes in 4351 patients with invaive breast carcinoma treated in a single institution. Cancer 103: 492-500, 2005
35. Chu KU, Turner RR, Hansen NM, et al.: Do all patients with sentinel node metastases from breast carcinoma need complete axillary node dissection? Ann Surg 229: 536-541, 1999
36. Turner RR, Chu KU, Qi K, et al.: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89: 574-581, 2000
37. Wong SL, Edwards MJ, Chao C, et al.: Predicting the status of the nonsentinel axillary nodes: a multicenter study. Arch Surg 136: 563-568, 2001
38. Sachdev U, Murphy K, Derzie A, Jaffer S, Bleiweiss IJ, Brower S: Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg 183: 213-217, 2002
39. Hwang RF, Krishnamurthy S, Hunt KK, et al.: Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10: 248-254, 2003
40. Degnim AC, Griffith KA, Sabel MS, et al.: Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients: a metaanalysis. Cancer 98: 2307-2315, 2003
41. Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F: Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg 139: 648-651, 2004
42. Saidi RF, Dudrick PS, Remine SG, Mittal VK: Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 70: 101-105, 2004
43. Viale G, Maiorano E, Mazzarol G, et al.: Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92: 1378-1384, 2001
44. Abdessalam SF, Zervos EE, Prasad M, et al.: Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 182: 316-320, 2001
45. Rahusen FD, Torrenga H, van Diest PJ, et al.: Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 136: 1059-1063, 2001
46. Changsri C, Prakash S, Sandweiss L, Bose S: Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Breast J 10: 392-397, 2004
47. Goyal A, Douglas-Jones A, Newcombe RG, et al.: Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer 40: 1731-1737, 2004
48. Viale G, Maiorano E, Prurevi G, et al.: Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241: 319-325, 2005
49. Kamath VJ, Giuliano R, Dauway EL, et al.: Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 136: 688-692, 2001
50. Stitzenberg KB, Meyer AA, Stern SL, et al.: Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg 237: 607-612, 2003
51. Weiser MR, Montgomery LL, Tan LK, et al.: Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 8: 145-149, 2001